Fortress Biotech, Inc.’s FBIO share price has dipped by 6.18%, which has investors questioning if this is right time to buy.

Krystal Biotech's gene therapy Vyjuvek gains European approval, expanding treatment options for rare skin disease dystrophic ...

Scientists have discovered a new type of immune defense in E. coli bacteria that turns viral infection machinery against the ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S.

Krystal Biotech ( NASDAQ: KRYS) said that the European Commission granted marketing authorization to Vyjuvek for the treatment of wounds in certain patients with dystrophic epidermolysis bullosa, or ...

A new family of enzymes enables precise cuts in single-stranded DNA, offering powerful new tools for genetic engineering and expanding possibilities in biotechnology ... Single-stranded DNA is also ...

The scientists noted the importance of involving medics in the biotechnology dialogue and dispelled myths linking GMOs to cancer. They pointed out the potential of technologies like gene therapy ...

An age-old question about which came first, the chicken or the egg, won't matter for a biotech startup that aims to make egg protein powder – used in baked goods and other foods – from ...